Partner
Dr. Henning C. Schneider draws on 25 years of experience to help German and international clients navigate complex M&A/PE transactions and corporate matters. He previously served as the Global Co-Chair of the firm’s Healthcare and Life Sciences Industry Group, as well as the Chair of the firm’s Corporate Department in Germany.
Dr. Schneider advises major corporates and PE firms across industries, including healthcare, life sciences, energy, financial services, and real estate, on major public and private M&A/PE transactions, as well as on stock corporation law.
Based on his work on multi-billion Euro signature deals, Dr. Schneider has earned a reputation with clients as a skillful innovator, balancing both legal and commercial needs.
Leading legal publications, including Financial Times, JUVE, Chambers, and Handelsblatt repeatedly rank Dr. Schneider as a leading lawyer in both general M&A/PE and healthcare/life sciences.
He writes regularly on legal topics and has authored several legal handbooks, including a handbook on corporate law Münchener Handbuch Gesellschaftsrecht 2021, 5th edition, Grabitz/Hilf, Law of the European Union 2021, 72nd edition.
Dr. Schneider is a member of several boards, including Chair of the American Chamber of Commerce, North Germany. He is an alumnus of the Studienstiftung des Deutschen Volkes and a Knight of the Order of St. John.
Dr. Schneider’s representative work includes M&A/PE, joint ventures, restructurings, and privatizations, for the following clients:
Latham’s #1 rankings reinforce firm’s position as a global transactional powerhouse.
Firm works on “a landmark deal in the European healthcare sector last year” that was “particularly complex”.